Home
About Us
People
R&D
News
Contact Us
News
Press Release
30
th
August 2021
EnZen Therapeutics Thirona Bio investment
SAN DIEGO, California, 30
th
August, 2021 – EnZen Therapeutics, Inc. (“EnZen”) and Thirona Bio, Inc. (“Thirona”) today announced that EnZen has invested in Thirona under a convertible promissory note arrangement.